OpenAI’s Free ChatGPT for Doctors Triggers Doximity Stock Slide
OpenAI launched ChatGPT for doctors to help with notes and research. It’s free in the US, boosts AI use, and Doximity stock fell.
/ 29 items
#XY News-Driven Stocks↓
Trump Administration Set to Reclassify Marijuana This Week
The Trump administration is expected to reclassify marijuana from Schedule I to Schedule III as soon as this week, easing research barriers after months of delay.
$8 Billion Opportunity: Inhibrx’s Experimental Cancer Drug Draws Major Interest
Inhibrx is drawing strong interest from Merck and other big pharma for its experimental cancer drug INBRX-106 that could boost Keytruda. Potential $9B spin-off value.
CVC and GTCR Team Up to Take Medical Device Maker Teleflex Private
Private equity firms CVC Capital Partners and GTCR have submitted a joint offer to take medical device company Teleflex (TFX) private. Shares jumped on the news.
Citi: Amazon’s Cheap GLP-1 Renewals Could Hurt Hims — But Not Replace It
Citi analysts say Amazon One Medical’s new $29 on-demand GLP-1 prescription renewals could pressure Hims & Hers, but they are not a full replacement for the telehealth weight-loss giant.
Mizuho Upgrades Outlook: Harmony’s Wakix Now Protected Until 2030
Harmony Biosciences wins key patent lawsuit, protecting Wakix from generics until ~2030; analyst stays positive with $50 target.